|
MAT2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.297500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.559880E-02 |
| Normal-vs-Stage2 |
2.679900E-02 |
| Normal-vs-Stage3 |
1.258430E-03 |
| Normal-vs-Stage4 |
8.437000E-01 |
| Stage1-vs-Stage2 |
6.621400E-01 |
| Stage1-vs-Stage3 |
2.160400E-01 |
| Stage1-vs-Stage4 |
7.785000E-01 |
| Stage2-vs-Stage3 |
5.820800E-01 |
| Stage2-vs-Stage4 |
7.054000E-01 |
| Stage3-vs-Stage4 |
5.988200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.758400E-03 |
| Normal-vs-AfricanAmerican |
5.022100E-03 |
| Normal-vs-Asian |
4.781200E-03 |
| Caucasian-vs-AfricanAmerican |
5.529400E-01 |
| Caucasian-vs-Asian |
2.399800E-01 |
| AfricanAmerican-vs-Asian |
1.896440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.682600E-03 |
| Normal-vs-Female |
2.665700E-02 |
| Male-vs-Female |
8.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.156240E-01 |
| Normal-vs-Extreme_Weight |
3.442400E-03 |
| Normal-vs-Obese |
3.244000E-02 |
| Normal-vs-Extreme_Obese |
7.280200E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.296400E-01 |
| Normal_Weight-vs-Obese |
9.249000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.447400E-01 |
| Extreme_Weight-vs-Obese |
3.279200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.038600E-01 |
| Obese-vs-Extreme_Obese |
2.939800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.927600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.692000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.017100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.859580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.647400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.456600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.598400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.733050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.663400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.351800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.254250E-02 |
| Normal-VS-Type2 PRCC |
6.479500E-02 |
| Normal-VS-KIRP CIMP |
1.86629999998633E-06 |
| Normal-VS-Unclassified PRCC |
1.764010E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.932000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.591100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.160400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.024000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.597400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.679700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.764350E-04 |
| Normal-vs-N1 |
5.779200E-01 |
| Normal-vs-N2 |
9.641800E-03 |
| N0-vs-N1 |
3.770600E-01 |
| N0-vs-N2 |
1.840240E-01 |
| N1-vs-N2 |
4.101800E-01 |
|
|
